Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

In-Office Pharmacist Improves Patient Care

Karen Appold  |  May 26, 2017

As a result of these efforts, Dr. Shapiro says the approval process for an off-label drug usage request is expedited. In fact, the letters have been so effective that Dr. Farrell contracted with the ACR to provide template letters members can download and tailor to their needs. Current available letters include adalimumab (Humira) for sarcoidosis and rituximab (Rituxan) for myositis.

Jessica Farrell, PharmD

Added Care & Benefits
Because she works with all of the practice’s providers and sees a larger number of patients, Dr. Farrell has developed expertise in medication management in special populations, such as patients with rheumatoid arthritis (RA) who are pregnant or breastfeeding. “By staying up to date on the latest research, I can counsel these patients on the risks vs. the benefits and help them make evidence-based decisions regarding medications,” she says.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The pharmacy team also reports adverse reactions to the U.S. Food and Drug Administration’s MedWatch program, which is time consuming for physicians. This change has increased the practice’s efficiency in reporting these events. Dr. Farrell also provides regular pharmacy updates tailored to the practice’s needs, which serves as a quick reference for busy clinicians and staff.

Dr. Shapiro feels very fortunate to have partnered with the pharmacy school, because the practice doesn’t have to pay for the pharmacy services. He would advise other rheumatology practices to pursue such an arrangement. “The larger your practice, the greater the argument you have for adding a pharmacist,” he says. “If you have a pharmacy school in your city, I suggest working to establish an affiliation.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

If a school isn’t nearby and hiring a full-time pharmacist isn’t feasible, Dr. Farrell recommends considering a part-time pharmacist. By simply assisting with insurance authorization, she believes a pharmacist can potentially free up a rheumatologist’s time to see more patients or spend more time with complex patients and provide better overall care. This increased efficiency may result in increased revenue because the practice will have time to see more patients—offsetting the pharmacist’s cost. In addition, Dr. Farrell uses incident-to physician billing for medication counseling visits, which generates revenue.

Although Dr. Farrell didn’t have rheumatology expertise when she first started at the practice, she acquired it by working with providers and staying abreast of current medication trends in rheumatology. Now, she even speaks regularly—both locally and nationally—on medication management in rheumatic diseases.


Karen Appold is a medical writer in Pennsylvania.

Page: 1 2 3 | Single Page
Share: 

Filed under:Practice SupportWorkforce Tagged with:patient educationpharmacistpharmacologypharmacyPractice Managementrheumatology practice

Related Articles

    Rheumatology Clinics Add Pharmacists to Care Teams, See Benefits

    January 17, 2019

    CHICAGO—Could the addition of a pharmacist to rheumatology care teams improve patient satisfaction, decrease staff burnout or reduce medication-related problems? Three panelists in Integrating Pharmacists into the Workforce, a session at the 2018 ACR/ARHP Annual Meeting, shared positive experiences with this interdisciplinary care model. Less Burnout, More Satisfaction Ten years ago, the Arthritis Treatment Center…

    Jessica Farrell, PharmD, in the Spotlight: Why the ARP Is for Me

    December 18, 2018

    It was never in the plan for Jessica Farrell, PharmD, to enter rheumatology. In fact, when she applied for one of two pharmacist positions at Albany College of Pharmacy and Health Sciences in 2008, she made it clear she was only interested in the family practice position. “I was offered an interview for the family…

    What Pharmacists Want Rheumatologists to Know

    May 18, 2019

    Involving pharmacists in the management of chronic diseases benefits patients, says Wendy Ramey, BSPharm, RPh, CSP, a clinical pharmacy specialist in rheumatology at the University of Kentucky, Lexington. She knows this personally. As someone with rheumatoid arthritis (RA), Ms. Ramey knows pharmacists can play an important role in patient education and encouraging adherence to medications….

    DMARDs & Biologics Info for Rheumatology Nurses

    March 17, 2018

    SAN DIEGO—In a presentation on what rheumatology nurses should know in their daily practice about disease-modifying anti-rheumatic drugs (DMARDs) at the 2017 ACR/ARHP Annual Meeting Nov. 3–8, Jessica Farrell, PharmD, highlighted the importance of educating and counseling patients about the range of treatments and applications for rheumatologic conditions. Dr. Farrell, a clinical pharmacist at the…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences